Literature DB >> 19605677

High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus.

Edmund K Li1, Lai Shan Tam, James F Griffith, Tracy Y Zhu, Tena K Li, Martin Li, Kong Chiu Wong, Michael Chan, Christopher W Lam, Ferdinand S Chu, Ka Kin Wong, Ping Chung Leung, Anthony Kwok.   

Abstract

OBJECTIVE: To investigate the prevalence of vertebral fractures and to identify risk factors associated with vertebral fractures in Chinese women with systemic lupus erythematosus (SLE).
METHODS: One hundred fifty-two consecutive patients with SLE were recruited in this cross-sectional study. Bone mineral density (BMD) measurements of the hip and spine were performed using the same dual energy X-ray absorptiometry (DEXA). Lateral radiographs of the spine (T5-L4) were assessed for vertebral fractures using a method described by Genant. Inflammatory and biochemical markers included C-reactive protein, receptor activator of nuclear factor-kappaB ligand, serum ss-CrossLaps assay for C-terminal telopeptides of type 1 collagen, and osteoprotegerin (OPG).
RESULTS: Asymptomatic vertebral fractures occurred in 20.4% of patients with SLE. Univariate analyses of variables associated with fractures were older age, higher body mass index (BMI), lower BMD spine, lower BMD hips, higher serum C3 and C4, longer estrogen exposure, higher levels of OPG, and the use of sunscreen. Multivariate analysis showed older age (p = 0.017), higher BMI (p < 0.036), and lower BMD of the spine were significantly associated with vertebral fractures in the thoracic and/or lumbar spine (odds ratio 1.068, 1.166, 0.005; p = 0.018, p = 0.025, p = 0.003, respectively).
CONCLUSION: Asymptomatic vertebral fractures occur in 20.4% of patients with SLE and 30% of these patients have normal BMD. The current method using DEXA to predict the presence of vertebral fracture has limited value and there is a need for assessment of bone quality. Vertebral morphometry in patients with SLE is recommended and early therapeutic intervention is necessary to prevent vertebral fractures in patients with SLE.

Entities:  

Mesh:

Year:  2009        PMID: 19605677     DOI: 10.3899/jrheum.081337

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  24 in total

1.  Significantly higher estimated 10-year probability of fracture in lupus patients with bone mineral density comparable to that of healthy individuals.

Authors:  Anselm Mak; Jia Qing Lim; Yang Liu; Alicia Ai-cia Cheak; Roger Chun-man Ho
Journal:  Rheumatol Int       Date:  2012-03-24       Impact factor: 2.631

Review 2.  Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  X Wang; S Yan; C Liu; Y Xu; L Wan; Y Wang; W Gao; S Meng; Y Liu; R Liu; D Xu
Journal:  Osteoporos Int       Date:  2016-01-11       Impact factor: 4.507

Review 3.  Inflammatory diseases and bone fragility.

Authors:  K Briot; P Geusens; I Em Bultink; W F Lems; C Roux
Journal:  Osteoporos Int       Date:  2017-09-15       Impact factor: 4.507

4.  Cortical thinning and progressive cortical porosity in female patients with systemic lupus erythematosus on long-term glucocorticoids: a 2-year case-control study.

Authors:  T Y Zhu; J F Griffith; L Qin; V W Y Hung; T-N Fong; S-K Au; X-L Tang; E W Kun; A W Kwok; P-C Leung; E K Li; L-S Tam
Journal:  Osteoporos Int       Date:  2015-03-04       Impact factor: 4.507

Review 5.  Traditional and Non-traditional Risk Factors for Osteoporosis in CKD.

Authors:  Hanne Skou Jørgensen; Karel David; Syazrah Salam; Pieter Evenepoel
Journal:  Calcif Tissue Int       Date:  2021-02-14       Impact factor: 4.333

6.  High frequency of osteoporosis and fractures in women with dermatomyositis/polymyositis.

Authors:  Danieli Castro Oliveira de Andrade; Sonia Cristina de Magalhães Souza; Jozélio Freire de Carvalho; Liliam Takayama; Claudia Teresa Lobato Borges; José Mendes Aldrighi; Rosa Maria Rodrigues Pereira
Journal:  Rheumatol Int       Date:  2011-02-16       Impact factor: 2.631

7.  Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.

Authors:  Edmund K Li; Tracy Y Zhu; Vivian Y Hung; Anthony W Kwok; Vivian W Lee; Kenneth K Lee; James F Griffith; Martin Li; Kong Chiu Wong; Ping Chung Leung; Ling Qin; Lai Shan Tam
Journal:  Arthritis Res Ther       Date:  2010-10-22       Impact factor: 5.156

8.  Prevalence and risk factors of vertebral compression fractures in female SLE patients.

Authors:  Katarina Almehed; Szabolcs Hetényi; Claes Ohlsson; Hans Carlsten; Helena Forsblad-d'Elia
Journal:  Arthritis Res Ther       Date:  2010-08-02       Impact factor: 5.156

9.  Prevalence and predictors of low bone density and fragility fractures in women with systemic lupus erythematosus in a Mediterranean region.

Authors:  Tarek Carlos Salman-Monte; Vicenç Torrente-Segarra; Juan Muñoz-Ortego; Sergi Mojal; Jordi Carbonell-Abelló
Journal:  Rheumatol Int       Date:  2014-07-17       Impact factor: 2.631

10.  Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT.

Authors:  X L Tang; L Qin; A W Kwok; T Y Zhu; E W Kun; V W Hung; J F Griffith; P C Leung; E K Li; L-S Tam
Journal:  Osteoporos Int       Date:  2012-10-27       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.